Accumulation of fetal IgG in immunoglobulin injection into the fetal abdominal cavity is proven

Fetal Diagnosis and Therapy

Volumn 29, Issue 3, 2011, Pages 229-232

  Yoshida, Masashi ^a   Matsuda, Hideo ^a   Hasegawa, Yuri ^a   Yoshinaga, Yosuke ^a   Asai, Kazuhiko ^a   Kawashima, Akihiro ^a   Furuya, Kenichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Fetal hemodynamics; IgG subclass; Immunoglobulin injection into fetal abdominal cavity; Immunohistochemistry; Intrauterine treatment

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4;

ADULT; ARTICLE; BLOOD GROUP INCOMPATIBILITY; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; FETAL THERAPY; FETUS; FETUS CIRCULATION; HEMODYNAMICS; HUMAN; IMMUNOHISTOCHEMISTRY; PERITONEAL CAVITY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ABDOMINAL CAVITY; BLOOD CIRCULATION; BLOOD GROUP INCOMPATIBILITY; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETAL BLOOD; FETAL THERAPIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UMBILICAL VEINS;

EID: 79955030811     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322041     Document Type: Article

References (16)

1. Negishi H, Yamada H, Hirayama E, et al: Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus. J Perinatol 1998;18:466-469. (Pubitemid 128454166)
2. Matsuda H, Kawakami Y, Furuya K, et al: Intrauterine therapy for a cytomegalovirus-infected symptomatic fetus. BJOG 2004;111:756-757. (Pubitemid 38869767)
3. Matsuda H, Sakaguchi K, Shibasaki T, et al: Intrauterine therapy for parvovirus B19-infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin. J Perinat Med 2005;33:561-563. (Pubitemid 41769718)
4. Nigro G, Adler SP, La Torre R, et al: Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-1362. (Pubitemid 41362703)
5. Adler SP, Nigro G: Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol 2009;46(suppl 4): S54-S57.
6. Luppi P: How immune mechanisms are affected by pregnancy. Vaccine 2003;21:3352-3357. (Pubitemid 36792085)
7. Simister NE: Placental transport of immunoglobulin G. Vaccine 2003;21:3365-3369. (Pubitemid 36792087)
8. Gitlin D, Boesman M: Serum α-fetoprotein, albumin, and γ-globulin in the human conceptus. J Clin Invest 1966;45:1826-1838.
9. 2 -macroglobulin, and prealbumin in the human conceptus. J Clin Invest 1969;48:1433-1446.
10. Israel EJ, Simister N, Freiberg E, et al: Immunoglobulin G binding sites on the foetal intestine: a possible mechanism for the passive transfer of immunity from mother to infant. Immunology 1993;79:77-81. (Pubitemid 23151196)
11. Cederqvist LL, Ewool LC, Bonsnes RW, et al: Detectability and pattern of immunoglobulins in normal amniotic fluid throughout gestation. Am J Obstet Gynecol 1978;130:220-224. (Pubitemid 8286325)
12. Malek A: Ex vivo human placenta models: transport of immunoglobulin G and its subclasses. Vaccine 2003;21:3362-3364. (Pubitemid 36792086)
13. Garty BZ, Ludomirsky A, Danon YL, et al: Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol 1994;1:667-669. (Pubitemid 2164290)
14. Shrim A, Garcia-Bournissen F, Maxwell C, et al: Favorable pregnancy outcome following trastuzumab (Herceptin) use during pregnancy: case report and updated literature review. Reprod Toxicol 2007;23:611-613. (Pubitemid 46754746)
15. Roopenian DC, Akilesh S: FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007;7:715-725. (Pubitemid 47327396)
16. Burns JC, Capparelli EV, Brown JA, et al: Intravenous γ-globulin and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998;17:1144-1148. (Pubitemid 29023891)